3,097
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Modified Zhibai Dihuang pill alleviated urinary tract infection induced by extended-spectrum β-lactamase Escherichia coli in rats by regulating biofilm formation

, , , &
Pages 674-682 | Received 29 Sep 2022, Accepted 02 Apr 2023, Published online: 25 Apr 2023

References

  • Barrett P, Flower A, Lo V. 2015. What’s past is prologue: Chinese medicine and the treatment of recurrent urinary tract infections. J Ethnopharmacol. 167:86–96.
  • Bayne K. 1996. Revised guide for the care and use of laboratory animals available. American Physiological Society. Physiologist. 39:199, 208–111.
  • Behzadi P, Behzadi E. 2008. The microbial agents of urinary tract infections at central laboratory of Dr. Shariati Hospital, Tehran, IRAN. Turkiye Klinikleri J Med Sci. 28:445–449.
  • Behzadi P, García-Perdomo HA, Karpiński TM, Issakhanian L. 2020. Metallo-β-lactamases: a review. Mol Biol Rep. 47(8):6281–6294.
  • Behzadi P. 2020. Classical chaperone-usher (CU) adhesive fimbriome: uropathogenic Escherichia coli (UPEC) and urinary tract infections (UTIs). Folia Microbiol (Praha). 65(1):45–65.
  • Behzadi P, Behzadi E. 2017. Uropathogenic Escherichia coli: an ideal resource for DNA microarray probe designing. Bioinform Biomed Eng. 10209:12–19.
  • Chang CH, Wu JB, Yang JS, Lai YJ, Su CH, Lu CC, Hsu YM. 2017. The suppressive effects of geniposide and genipin on Helicobacter pylori infections in vitro and in vivo. J Food Sci. 82(12):3021–3028.
  • Chen L, Wen YM. 2011. The role of bacterial biofilm in persistent infections and control strategies. Int J Oral Sci. 3(2):66–73.
  • Chen XP, Ali L, Wu LY, Liu C, Gang CX, Huang QF, Ruan JH, Bao SY, Rao YP, Yu D. 2018. Biofilm formation plays a role in the formation of multidrug-resistant Escherichia coli toward nutrients in microcosm experiments. Front Microbiol. 9:367.
  • Choe HS, Lee SJ, Yang SS, Hamasuna R, Yamamoto S, Cho YH, Matsumoto T. 2018. Summary of the UAA-AAUS guidelines for urinary tract infections. Int J Urol. 25(3):175–185.
  • Coffey BM, Anderson GG. 2014. Biofilm formation in the 96-well microtiter plate. Methods Mol Biol. 1149:631–641.
  • Flores-Mireles A, Hreha TN, Hunstad DA. 2019. Pathophysiology, treatment, and prevention of catheter-associated urinary tract infection. Top Spinal Cord Inj Rehabil. 25(3):228–240.
  • Gupta K, Grigoryan L, Trautner B. 2017. Urinary tract infection. Ann Intern Med. 167(7):Itc49–itc64.
  • Herrmann V, Palma P, Géo MS, Lima RS. 2002. Urinary tract infections: pathogenesis and related conditions. Int Urogynecol J Pelvic Floor Dysfunct. 13(3):210–213.
  • Hou Y, Yang M, Jiang H, Li D, Du Y. 2019. Effects of low-intensity and low-frequency ultrasound combined with tobramycin on biofilms of extended-spectrum beta-lactamases (ESBLs) Escherichia coli. FEMS Microbiol Lett. 366:026.
  • Hozzari A, Behzadi P, Kerishchi Khiabani P, Sholeh M, Sabokroo N. 2020. Clinical cases, drug resistance, and virulence genes profiling in uropathogenic Escherichia coli. J Appl Genet. 61(2):265–273.
  • Issakhanian L, Behzadi P. 2019. Antimicrobial agents and urinary tract infections. Curr Pharm Des. 25(12):1409–1423.
  • Johansson SL, Anderström C, Schultz L, Larsson P. 1987. Enhancement of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced carcinogenesis by urinary tract infection in rats. Cancer Res. 47:559–562.
  • Jorgensen JH, Ferraro MJ. 2009. Antimicrobial susceptibility testing: a review of general principles and contemporary practices. Clin Infect Dis. 49(11):1749–1755.
  • Kai K. 2018. Bacterial quorum sensing in symbiotic and pathogenic relationships with hosts. Biosci Biotechnol Biochem. 82(3):363–371.
  • Khonsari MS, Behzadi P, Foroohi F. 2021. The prevalence of type 3 fimbriae in uropathogenic Escherichia coli isolated from clinical urine samples. Meta Gene. 28:100881.
  • Kostakioti M, Hadjifrangiskou M, Hultgren SJ. 2013. Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era. Cold Spring Harb Perspect Med. 3(4):a010306.
  • Leoney A, Karthigeyan S, Asharaf AS, Felix AJW. 2020. Detection and categorization of biofilm-forming Staphylococcus aureus, Viridans streptococcus, Klebsiella pneumoniae, and Escherichia coli isolated from complete denture patients and visualization using scanning electron microscopy. J Int Soc Prev Community Dent. 10(5):627–633.
  • Li JJ, Tu YY, Tong JZ, Wang PT. 2000. [Inhibitory activity of Dianthus superbus L. and 11 kinds of diuretic Traditional Chinese medicines for urogenital Chlamydia trachomatis in vitro]. Zhongguo Zhong Yao Za Zhi. 25:628–630. Chinese
  • Li XQ, Zhu JY, Pan RR, Shen YL, Rahman K, Zhang CY, Zhang LJ, Luan X, Zhang H. 2019. Therapeutic effect of Dongbai-Tonglin-Fang, a Chinese herbal formula, on urinary tract infection in rat model. J Ethnopharmacol. 241:112028.
  • Liu CM, Chen J, Yang S, Mao LG, Jiang TT, Tu HH, Chen ZL, Hu YT, Gan L, Li ZJ, et al. 2018. The Chinese herbal formula Zhibai Dihuang Granule treat Yin-deficiency-heat syndrome rats by regulating the immune responses. J Ethnopharmacol. 225:271–278.
  • Liu SW, Guo J, Wu WK, Chen ZL, Zhang N. 2019. Treatment of uncomplicated recurrent urinary tract infection with Chinese medicine formula: a randomized controlled trial. Chin J Integr Med. 25(1):16–22.
  • Liu SW, Xu XY, Xu J, Yuan JY, Wu WK, Zhang N, Chen ZL. 2017. Multi-drug resistant uropathogenic Escherichia coli and its treatment by Chinese medicine. Chin J Integr Med. 23(10):763–769.
  • Ma Q, Wood TK. 2009. OmpA influences Escherichia coli biofilm formation by repressing cellulose production through the CpxRA two-component system. Environ Microbiol. 11(10):2735–2746.
  • Ma Y, Chen M, Guo Y, Liu J, Chen W, Guan M, Wang Y, Zhao X, Wang X, Li H, et al. 2019. Prevention and treatment of infectious diseases by traditional Chinese medicine: a commentary. APMIS. 127(5):372–384.
  • Millner R, Becknell B. 2019. Urinary tract infections. Pediatr Clin North Am. 66(1):1–13.
  • Muhammad MH, Idris AL, Fan X, Guo Y, Yu Y, Jin X, Qiu J, Guan X, Huang T. 2020. Beyond risk: Bacterial biofilms and their regulating approaches. Front Microbiol. 11:928.
  • Ozawa A, Sakaue M. 2020. New decolorization method produces more information from tissue sections stained with hematoxylin and eosin stain and Masson-trichrome stain. Ann Anat. 227:151431.
  • Park HJ, Lee JY, Moon SS, Hwang BK. 2003. Isolation and anti-oomycete activity of nyasol from Anemarrhena asphodeloides rhizomes. Phytochemistry. 64(5):997–1001.
  • Pavithra D, Doble M. 2008. Biofilm formation, bacterial adhesion and host response on polymeric implants–issues and prevention. Biomed Mater. 3(3):034003.
  • Rabin N, Zheng Y, Opoku-Temeng C, Du Y, Bonsu E, Sintim HO. 2015. Biofilm formation mechanisms and targets for developing antibiofilm agents. Future Med Chem. 7(4):493–512.
  • Saremi J, Kargar Jahromi H, Pourahmadi M. 2018. Effect of Polygonum aviculare L. on nephrolithiasis induced by ethylene glycol and ammonium chloride in rats. Urol J. 15:79–82.
  • Sarshar M, Behzadi P, Ambrosi C, Zagaglia C, Palamara AT, Scribano D. 2020. FimH and anti-adhesive therapeutics: A disarming strategy against uropathogens. Antibiotics (Basel). 9(7):397.
  • Shi T, Li T, Jiang X, Jiang X, Zhang Q, Wang Y, Zhang Y, Wang L, Qin X, Zhang W, et al. 2020. Baicalin protects mice from infection with methicillin-resistant Staphylococcus aureus via alleviating inflammatory response. J Leukoc Biol. 108(6):1829–1839.
  • Shrestha R, Khanal S, Poudel P, Khadayat K, Ghaju S, Bhandari A, Lekhak S, Pant ND, Sharma M, Marasini BP. 2019. Extended spectrum β-lactamase producing uropathogenic Escherichia coli and the correlation of biofilm with antibiotics resistance in Nepal. Ann Clin Microbiol Antimicrob. 18(1):42.
  • Sun T, Li XD, Hong J, Liu C, Zhang XL, Zheng JP, Xu YJ, Ou ZY, Zheng JL, Yu DJ. 2019. Inhibitory effect of two traditional Chinese medicine monomers, berberine and matrine, on the quorum sensing system of antimicrobial-resistant Escherichia coli. Front Microbiol. 10:2584.
  • Sun Y, Lenon GB, Yang AWH. 2019. Phellodendri cortex: a phytochemical, pharmacological, and pharmacokinetic review. Evid Based Complement Alternat Med. 2019:7621929.
  • Tandogdu Z, Wagenlehner FM. 2016. Global epidemiology of urinary tract infections. Curr Opin Infect Dis. 29(1):73–79.
  • Tremblay YD, Hathroubi S, Jacques M. 2014. [Bacterial biofilms: their importance in animal health and public health]. Can J Vet Res. 78:110–116.
  • Vikram A, Jayaprakasha GK, Jesudhasan PR, Pillai SD, Patil BS. 2010. Suppression of bacterial cell-cell signalling, biofilm formation and type III secretion system by Citrus flavonoids. J Appl Microbiol. 109(2):515–527.
  • Vuotto C, Longo F, Pascolini C, Donelli G, Balice MP, Libori MF, Tiracchia V, Salvia A, Varaldo PE. 2017. Biofilm formation and antibiotic resistance in Klebsiella pneumoniae urinary strains. J Appl Microbiol. 123(4):1003–1018.
  • Waller TA, Pantin SAL, Yenior AL, Pujalte GGA. 2018. Urinary tract infection antibiotic resistance in the United States. Prim Care. 45(3):455–466.
  • Wang J, Bao B, Meng F, Deng S, Dai H, Feng J, Li H, Wang B. 2021. To study the mechanism of Cuscuta chinensis Lam. and Lycium barbarum L. in the treatment of asthenospermia based on network pharmacology. J Ethnopharmacol. 270:113790.
  • Wang X, Li S, Lu X, Hu P, Chen H, Li Z, Bu Z, Lang X, Wang X. 2016. Rapid method of luxS and pfs gene inactivation in enterotoxigenic Escherichia coli and the effect on biofilm formation. Mol Med Rep. 13(1):257–264.
  • Williams P. 2002. Quorum sensing: an emerging target for antibacterial chemotherapy? Expert Opin Ther Targets. 6(3):257–274.
  • Xue WY, Qi JC, Du L. 2017. Intervention effect and mechanism of curcumin in chronic urinary tract infection in rats. Asian Pac J Trop Med. 10(6):594–598.
  • Yi WJ, Chen J, Li ZB, Jiang TT, Bi DQ, Liu CM, Yang S, Hu YT, Gan L, Tu HH, et al. 2020. Screening of potential biomarkers for Yin-deficiency-heat syndrome based on UHPLC-MS method and the mechanism of Zhibai Dihuang granule therapeutic effect. Anat Rec (Hoboken). 303(8):2095–2108.
  • Yu GY, Tian ZJ, Sun Y, Yang HW, Han SJ, Miao RP, Fu XW, Xiong M, Wang YX, Tian JJ. 2017. [Review on advantages and evidence of treating and preventing urinary tract infection in traditional Chinese medicine]. Zhongguo Zhong Yao Za Zhi. 42:1439–1448. Chinese
  • Zhang HW, Lin ZX, Xu C, Leung C, Chan LS. 2014. Astragalus (a traditional Chinese medicine) for treating chronic kidney disease. Cochrane Database Syst Rev. 22:Cd008369.
  • Zhang L, Liang E, Cheng Y, Mahmood T, Ge F, Zhou K, Bao M, Lv L, Li L, Yi J, et al. 2020. Is combined medication with natural medicine a promising therapy for bacterial biofilm infection? Biomed Pharmacother. 128:110184.
  • Zhang N, Huang L, Liu S, Wang Y, Luo Y, Jin X, Guo J, Ke Y, Chen J, Yuan X, et al. 2013. Traditional Chinese medicine: an alternative treatment option for refractory recurrent urinary tract infections. Clin Infect Dis. 56(9):1355.
  • Zhao H, Xu J, Wang R, Tang W, Kong L, Wang W, Wang L, Zhang Y, Ma W. 2021. Plantaginis semen polysaccharides ameliorate renal damage through regulating NLRP3 inflammasome in gouty nephropathy rats. Food Funct. 12(6):2543–2553.
  • Zhao YY, Feng YL, Bai X, Tan XJ, Lin RC, Mei Q. 2013. Ultra performance liquid chromatography-based metabonomic study of therapeutic effect of the surface layer of Poria cocos on adenine-induced chronic kidney disease provides new insight into anti-fibrosis mechanism. PLoS One. 8(3):e59617.
  • Zhao ZG, Yan SS, Yu YM, Mi N, Zhang LX, Liu J, Li XL, Liu F, Xu JF, Yang WQ, et al. 2013. An aqueous extract of Yunnan Baiyao inhibits the quorum-sensing-related virulence of Pseudomonas aeruginosa. J Microbiol. 51(2):207–212.
  • Zowawi HM, Harris PN, Roberts MJ, Tambyah PA, Schembri MA, Pezzani MD, Williamson DA, Paterson DL. 2015. The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nat Rev Urol. 12(10):570–584.